THMO ThermoGenesis Dashboard

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Company profile

Ticker

THMO

Exchange

NASDAQ

Website

thermogenesis.com

CEO

Xiaochun Xu

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Other Industrial Machinery Manufacturing

Industry (SIC)

Laboratory Apparatus & Furniture

Kewaunee Scientific • Misonix • Reflect Scientific ...

Former names

CESCA THERAPEUTICS INC., THERM0GENESIS CORP, THERMOGENESIS CORP

SEC CIK

0000811212

Corporate docs

Articles of Incorporation & Bylaws

IRS number

943018487

THMO stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

ThermoGenesis Holdings Shares Move Higher On Volume; Traders Circulate June 17, 2020 PR From Co Highlighting Results Of ImmuneCyte's Licensed Neutralizing Antibody Therapeutics For COVID-19

26 Jul 21

https://www.hospimedica.com/covid-19/articles/294783005/thermogenesis-announces-publishing-of-results-of-immunecytes-licensed-neutralizing-antibody-therapeutics-for-covid-19.html

12 Health Care Stocks Moving In Friday's After-Market Session

4 Jun 21

Gainers

12 Health Care Stocks Moving In Monday's After-Market Session

24 May 21

Gainers

Recap: ThermoGenesis Holdings Q1 Earnings

13 May 21

ThermoGenesis Holdings Q1 EPS $(0.21) Misses $(0.13) Estimate, Sales $1.50M Miss $2.66M Estimate

13 May 21

Press releases

Pro users get this 30m faster

ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2021 and Provides Corporate Update

13 May 21

RANCHO CORDOVA, Calif., May 13, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ:THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported

ThermoGenesis Holdings, Inc. to Host Earnings Call

13 May 21

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / ThermoGenesis Holdings, Inc. (NASDAQ:THMO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

6 May 21

RANCHO CORDOVA, Calif., May 6, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ:THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

13 May 21

29 Jul 21

31 Dec 21

Financial summary

Financial statements Chart THMO financial data

Quarter (USD)	Mar 21	Dec 20	Sep 20	Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Jun 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	10.01M	10.01M	10.01M	10.01M	10.01M	10.01M
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	554.33K	779.17K	1.32M	1.32M
Cash used (since last report)	n/a	n/a	2.19M	3.08M	5.21M	5.21M
Cash remaining	n/a	n/a	7.82M	6.93M	4.8M	4.8M
Runway (months of cash)	n/a	n/a	14.1	8.9	3.6	3.6

Beta Read what these cash burn values mean

Recent insider trades

THMO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
27 May 21	Cauble Jeffery	Stock Option Common Stock	Sale back to company	Dispose D	No	No	5.94	40,000	237.6K	0
27 May 21	Xu Xiaochun	Stock Option Common Stock	Sale back to company	Dispose D	No	No	5.94	240,000	1.43M	0
4 Jun 20	Donaghy Debra	Stock Option Common Stock	Grant	Aquire A	No	No	5.94	10,000	59.4K	10,000
4 Jun 20	Westgate Mark	Stock Option Common Stock	Grant	Aquire A	No	No	5.94	10,000	59.4K	10,000
4 Jun 20	Joseph Thomis	Stock Option Common Stock	Grant	Aquire A	No	No	5.94	10,000	59.4K	10,000

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

THMO institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

3.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	16	0	NEW
Opened positions	16	0	NEW
Closed positions	0	15	EXIT
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	1.02M	0	NEW
Total shares	380.15K	0	NEW
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
BLK Blackrock	95.12K	$256K	NEW
Citadel Advisors	90.72K	$244K	NEW
Vanguard	68.97K	$186K	NEW
GS Goldman Sachs	49.77K	$134K	NEW
BAC Bank Of America	35.22K	$95K	NEW
Geode Capital Management	22.41K	$60K	NEW
NTRS Northern Trust	10.79K	$29K	NEW
Valeo Financial Advisors	3K	$8K	NEW
MS Morgan Stanley	2.07K	$6K	NEW
Tower Research Capital	943	$3K	NEW

Largest transactions	Shares	Bought/sold	Change
BLK Blackrock	95.12K	+95.12K	NEW
Citadel Advisors	90.72K	+90.72K	NEW
Vanguard	68.97K	+68.97K	NEW
GS Goldman Sachs	49.77K	+49.77K	NEW
BAC Bank Of America	35.22K	+35.22K	NEW
Geode Capital Management	22.41K	+22.41K	NEW
NTRS Northern Trust	10.79K	+10.79K	NEW
Valeo Financial Advisors	3K	+3K	NEW
MS Morgan Stanley	2.07K	+2.07K	NEW
Tower Research Capital	943	+943	NEW

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Baxter International • Vericel • BioCardia • Plus Therapeutics • Zimmer Biomet • Pluristem Therapeutics • Mesoblast • Celyad Oncology

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: absence, acquisition, ago, begun, Clarifying, contamination, Division, domestic, economy, fixed, foot, forgive, forgiven, forward, gain, governmental, Hedging, hopeful, iii, impossible, interaction, iv, KDWinfo, located, manipulation, maximizing, media, minimal, movement, multiple, negative, NOL, notified, outbreak, provision, rebound, red, rendered, reproducible, satisfied, SBA, Shangai, spread, square, subside, supernatant, tax, transition, travel, turn, volume

Removed: acceleration, acknowledgement, acknowledging, Additionally, administered, aforementioned, agreed, aid, allocate, allocated, alter, amounted, announced, announcing, antibody, appointed, approach, approval, argued, authorized, avoid, back, bankruptcy, bar, base, begin, bond, book, bring, Carlo, case, CECL, charge, China, Colloidal, Comerica, commercialization, commercially, compliant, conclusion, connection, constructive, consulting, contest, continuing, convalescent, court, covenant, daily, decision, declared, deduction, deemed, delay, dendritic, denied, deposited, detection, develop, discontinue, dismissal, disputing, distribute, distributor, divided, earlier, earliest, Economic, economically, effected, effecting, effectively, ego, eighteen, embedded, emerge, encountered, entering, entitle, entity, environment, equitable, estimated, estoppel, evenly, exceeded, exchangeable, exchanged, excluding, exercisable, expertise, expire, exploratory, extended, extent, face, favor, feasible, featured, field, File, firm, formation, formed, framework, free, GMP, Gold, goodwill, Gurgaon, healthier, holder, Hong, human, immunity, impaired, impose, incentive, inception, incremental, indemnification, India, Indonesia, infusion, institutional, instrument, intellectual, intent, involving, issue, issuing, judgment, June, jury, JV, kit, Kong, laboratory, lack, largest, launched, law, letter, leverage, license, lifetime, limited, long, longer, lowering, maker, merged, million, minimum, Monte, NASDAQ, newly, noncurrent, nonfinancial, notice, notification, objective, obligated, October, office, ordinary, originated, owed, owner, people, permitted, plasma, portion, posed, potentially, premium, prepayment, preserve, preventative, prohibited, project, proper, property, proposed, quickly, ratably, RDO, reached, reacquired, receipt, receive, recovered, reducing, register, registration, reimburse, reimbursed, relationship, release, Relief, remain, renew, reorganization, reportable, Republic, researching, respond, restated, restrict, restricted, retrieving, retroactively, reverse, royalty, ruling, Security, seeking, segment, settle, shelf, significantly, simulation, Singapore, size, software, space, split, stockholder, strategy, streamline, successful, successive, sufficient, summarize, Superior, supplement, SynGen, Taiwan, terminate, termination, test, thereof, thereon, thirty, trading, treat, trial, true, twelve, unconsolidated, uncontaminated, unfavorable, upfront, utilized, venture, verdict, winding, younger

From filing 10-Q 2021 Q1